The drug letrozole is produced by the company Cipla and is marketed under the brand name Fempro. Letrozole is an anti-oestrogenic drug known as an aromatase inhibitor (AI). The medication was initially developed to treat female breast cancer, but it is also used by men to regulate their oestrogen levels. Letrozole takes about 42 hours on average to start working. Although it is the strongest AI used in bodybuilding, Arimidex (Anastrozole) is the most widely used.
Properties and effects of Fempro
Although testosterone levels in men who use anabolic steroids that are susceptible to aromatization initially rise, the aromatase enzyme will soon begin converting the testosterone to oestrogen. Unwanted side effects happen when oestrogen levels in the male body rise too high. Letrozole use will aid in blocking the activity of aromatase, bringing down oestrogen production to a normal level and preventing adverse effects like gynecomastia or fluid retention.
Application and dosage for Letrozole
Letrozole dosages typically range from 1.25 mg to 2.5 mg per day. Every person should begin with a low dose of 1.25mg (half a tablet) and gradually increase or decrease it as needed based on how they feel their body is responding. For many anabolic steroid users, even 1.25mg per day is excessive. Given that letrozole’s half-life is between 2 and 4 days in this situation, a dose of 1.25 mg every 2 days, or even 3 to 4 days, is advised.
Side effects from Letrozole pills
Letrozole may cause headaches, general weakness, nausea, peripheral oedema, hot flashes, hair thinning, or mild to moderate rash, among other side effects.
Combination with other AAS
Sportspeople supplement their cycles with aromatase inhibitors like this letrozole from Cipla because they stop the rise in oestrogen levels brought on by oestrogen-producing steroids like Equipoise, Deca-Durabolin, testosterone, and Dianabol.
Reviews of Cipla’s Fempro
Sportsmen who need assistance lowering high oestrogen levels to combat the aromatization caused by some steroids prefer Cipla’s Fempro.
There are no reviews yet.